Vertex Pharmaceuticals Incorporated ( VRTX) - Key Metrics

VRTX Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q1 ? ? ? ?
2025Q4 $12.71 $4.69 ? ?
2025Q3 $12.04 $4.24 $4.86 $4.46
2025Q2 $11.55 $4.02 $4.18 $3.61
2025Q1 $10.78 $2.52 $3.19 $3.03

VRTX Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q1 ? ?
2025Q4 ? 24.16
2025Q3 ? 23.11
2025Q2 ? 27.66
2025Q1 ? 48.18

VRTX Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q1 1.14% ?
2025Q4 0.30% ?
2025Q3 1.14% ?
2025Q2 0.81% ?
2025Q1 0.62% ?

VRTX

Price: $446.95

52 week price:
362.50
507.92

Payout Ratio Range:
0.37%
24.93%

Earnings Per Share: 16.85 USD

P/E Ratio: 25.51

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.1 million

Ebitda: 142.2 million

Market Capitalization: 108.7 billion

Links: